Discussing innovation in the cloud computing space, with Jay Walker, Patent Properties chairman.» Read More
U.S. federal regulators will announce a settlement on Friday with former Fannie Mae executives over their alleged roles in a 2004 multibillion-dollar accounting scandal, a person familiar with the settlement said on Thursday.
A federal grand jury and the Securities and Exchange Commission have been investigating the anti-money laundering practices of Fidelity Investments, according to a report in the Boston Business Journal.
President Bush urged Congress on Friday to quickly pass an economic stimulus package void of extraneous spending, saying only quick action will kickstart the sputtering economy. "I strongly believe it would be a mistake to delay or derail this bill," Bush said.
Attorneys for the brothers of hedge fund manager Seth Tobias say his wife killed him because "Seth was worth substantially more to (her) dead than he was alive, and she knew that."
Internet phone company Vonage Holdings and Canadian telecommunications equipment maker Nortel Networks have settled their patent disputes, the companies said Monday.
Qualcomm won a round in its patent battles with wireless phone maker Nokia Wednesday as a U.S. trade court tossed out a lawsuit asking for Qualcomm's chips to be barred from the United States.
On Oct. 9, the U.S. Supreme Court will hear a case that some say may open the flood gates to a tidal wave of investor lawsuits. Legal experts joined CNBC to debate both sides of the issue.
Texas oilman Oscar Wyatt pleaded guilty Monday to conspiracy to commit wire fraud, one of five counts against him for his role in the U.N. oil-for-food scandal.
A U.S. federal court jury found that Vonage infringed on six Sprint Nextel patents, according to Sprint spokesman Matt Sullivan.
The cancer drug Erbitux unexpectedly extended survival in a trial of patients with advanced lung cancer, sending shares of its maker, ImClone Systems, soaring as much as 24 percent.
Millions of inventions pass quietly through the U.S. patent office each year. Patent No. 7,033,406 did, too, until energy insiders spotted six words in the filing that sounded like a death knell for the internal combustion engine.
A state judge in Michigan has sided with Wal-Mart Stores and dismissed a lawsuit by former marketing executive Julie Roehm over her firing, saying the case should be filed in Arkansas.
Qualcomm, hoping to rebound from a string of legal setbacks, urged a federal judge Tuesday to reject a competitor's request to stop it from selling cell phone chips that infringe on patents.
An amorous entrepreneur who created a "virtual bed" featured in Second Life, a Web site in which users can build their own Internet lives, is suing an unknown user for allegedly "stealing" the bed for his or her own virtual sexual fantasies. The lawsuit for copyright infringement is "inappropriate and unfair," said Andrew Langsam, an intellectual property lawyer at Pryor Cashman. He joined "Power Lunch" to talk about the nature of cyber-play.
Ariad Pharmaceuticals said a U.S. federal court ruled in favor of it and co-complainants in a patent infringement case against Eli Lilly, saying that the patent was valid and enforceable.
We can’t all be experts at everything, which is why we have people who are experts at something. Having said that, I’ll let you in on one of my little secrets -- how to tell when a pharmaceutical story has significance. ... Also: a seemingly innocuous headline -- about Expedia -- has plenty of hidden meaning.
The U.S. International Trade Commission ordered a ban on Thursday of some imported cell phone models containing Qualcomm chips that infringe on a Broadcom patent.
Bristol-Myers Squibb has agreed to pay a $1 million criminal fine for lying to the federal government about a patent deal involving its Plavix blood thinner, the Justice Department said.
The U.S. International Trade Commission said it extended by 13 days a deadline to decide what remedies, if any, to impose in a patent infringement complaint brought by Broadcom against rival Qualcomm.
The U.S. Supreme Court said it would not hear an appeal by drug maker Amgen that centers on how much leeway appeals courts should have in overruling the findings of lower courts in patent cases.